Department of Surgery, Kitasato University School of Medicine, Kanagawa, Japan.
Ann Surg Oncol. 2011 Sep;18(9):2432-41. doi: 10.1245/s10434-011-1625-3. Epub 2011 Mar 3.
Previous studies have suggested a detrimental prognostic effect of preoperative obstruction proximal to colorectal cancer (CRC). If such a detrimental effect is preserved in each stage of advanced (stage II or III) CRC, we can identify high-risk patients.
We enrolled 641 patients with pathologically confirmed advanced CRC (stage II, n = 207; stage III, n = 434) who had undergone curative resection of the primary lesion. The association of preoperative obstruction with clinicopathologic parameters was evaluated. Kaplan-Meier analysis and Cox proportional hazard models were used to estimate the effect of preoperative obstruction on disease-free survival in each stage.
Preoperative obstruction was seen in 63 patients (9.8%) (stage II, n = 16; stage III, n = 47). Multivariable analysis showed that preoperative obstruction was significantly associated with preoperative elevation of carcinoembryonic antigen level in patients with colon cancer (odds ratio = 3.59; P < 0.001), while it was correlated with poor differentiation in patients with rectal cancer (odds ratio = 3.99; P = 0.016). Preoperative obstruction was a significant prognostic factor in stage III CRC (P < 0.001), but not in stage II disease. Multivariable prognostic analysis showed that preoperative obstruction was a remnant independent prognostic factor in stage III CRC. This finding was confirmed by separate analyses of colon and rectal cancer. Preoperative obstruction was associated with systemic recurrence (P = 0.003) rather than peritoneal or local recurrence.
These findings suggest that preoperative obstruction may predict worse long-term prognosis in patients with stage III CRC and may be a potential clinical marker to identify patients with high-risk stage III CRC.
先前的研究表明,结直肠癌(CRC)近端术前梗阻与预后不良有关。如果这种有害影响在晚期(Ⅱ期或Ⅲ期)CRC 的各个阶段都存在,我们可以识别出高危患者。
我们纳入了 641 例经病理证实的晚期 CRC(Ⅱ期,n=207;Ⅲ期,n=434)患者,这些患者均接受了原发肿瘤的根治性切除。评估术前梗阻与临床病理参数之间的关系。采用 Kaplan-Meier 分析和 Cox 比例风险模型估计每个阶段术前梗阻对无病生存率的影响。
63 例(9.8%)患者存在术前梗阻(Ⅱ期,n=16;Ⅲ期,n=47)。多变量分析显示,术前梗阻与结肠癌患者术前癌胚抗原水平升高显著相关(优势比=3.59;P<0.001),而与直肠癌患者分化不良相关(优势比=3.99;P=0.016)。术前梗阻是Ⅲ期 CRC 的显著预后因素(P<0.001),但不是Ⅱ期疾病的预后因素。多变量预后分析显示,术前梗阻是Ⅲ期 CRC 的独立预后因素。这一发现通过对结肠癌和直肠癌的单独分析得到了证实。术前梗阻与全身复发相关(P=0.003),而与腹膜或局部复发无关。
这些发现表明,术前梗阻可能预示着Ⅲ期 CRC 患者的长期预后更差,并且可能是识别高危Ⅲ期 CRC 患者的潜在临床标志物。